[34] Robot-assisted partial nephrectomy: Initial experience from a single centre
Objective: To present Kuwait’s initial experience and outcomes of robot-assisted partial nephrectomy (RAPN) using the da Vinci® Si robot (Intuitive Surgical Inc., Sunnyvale, CA, USA), as advances in urology have focused on minimising the invasiveness of surgical procedures without compromising oncol...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Taylor & Francis Group
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/8c39c36267a84332a4a31f118ef9a597 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Objective: To present Kuwait’s initial experience and outcomes of robot-assisted partial nephrectomy (RAPN) using the da Vinci® Si robot (Intuitive Surgical Inc., Sunnyvale, CA, USA), as advances in urology have focused on minimising the invasiveness of surgical procedures without compromising oncological outcomes. Methods: After Institutional Review Board approval, data were recorded for all patients who underwent RAPN at our centre. Complications were graded using the Clavien–Dindo system and defining major complications as Grade ⩾III. Results: Between February 2014 and June 2018, a single surgeon’s robotic experience at Sabah Alahmad Urology Center (SAUC) included a total of 136 cases (116 cases as the main console surgeon and 20 cases with an invited robotic proctor). Of these, 25 cases (18%) were RAPN (21 cases as the main console surgeon and four cases with an invited robotic proctor). The mean age of the RAPN patients was 51 years. The mean size of the renal masses was 3 cm. The mean renal nephrometry score was 7.45. The most complex tumour had a score of 9 a+h. Eight tumours were posteriorly located. All patients underwent either warm or zero ischaemia PN. There was one major complication (Clavien–Dindo Grade IIIa), where a patient developed fever and perinephric urinoma requiring percutaneous drainage under local anaesthesia. The median hospital stay was 2 days. The mean estimated blood loss was 318 mL. Pathology included 22 malignant renal cell carcinomas (RCCs) with negative surgical margins and three benign tumours. One patient had two tumours resected from the same kidney during the same procedure and showed papillary type II and clear cell RCC. No tumour recurrence occurred over a mean follow-up of 15 months. Conclusion: Our centre’s initial RAPN experience shows good patient and operative outcomes. A larger number of cases are required to allow a definite conclusion. Dedication of all members of the robotic team is crucial to ensure good patient outcomes. |
|---|